Indo Borax Completes 64.26% Stake Acquisition in Kronox Lab Sciences
Indo Borax & Chemicals Ltd 路 Press Release 路 01 Oct 2026, 11:29 pm
Indo Borax Completes 64.26% Stake Acquisition in Kronox Lab Sciences Indo Borax & Chemicals completed the acquisition of a 64.26% controlling stake in Kronox Lab Sciences on 29th Sep'26, while erstwhile promoters retained 9.95%. Following the acquisition, Indo Borax reconstituted the board and appointed Suresh Kalra as MD & CEO for five years, alongside Shashikant Bharuka as CFO. Kronox manufactures high-purity speciality fine chemicals with a portfolio exceeding 185 products, generating approximately INR 101 crore in revenue and INR 28 crore in PAT for FY26.
Original exchange filing (PDF)
More announcements from Indo Borax & Chemicals Ltd
- Creation of further pledge over equity shares of Kronox Lab Sciences Limited. 路 18 Nov 2026
- Pursuant to regulation 30 of the Securities Exchange Borad of India (LODR) Regulations, 2015, please find enclosed herewith the press release on un-audited financial results for the quarter .... 路 11 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. 路 06 Nov 2026
- Indo Borax & Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 06 Nov 2026
- Disclosure under Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation regarding Creation of pledge over equity shares held in Kronox .... 路 04 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 06 Nov 2026
- INDO BORAX & CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 06 Nov 2026
- Indo Borax & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... 路 06 Nov 2026
